Form 4: NHC Executive Reports Stock Transactions
Statement of Changes in Beneficial Ownership
Stephen Flatt, CEO and Director of National Healthcare Corp (NHC), reported transactions involving stock options and common stock.
Summary
- Stephen Flatt, CEO and Director of National Healthcare Corp (NHC), reported several transactions on May 14, 2026.
- These transactions include the acquisition of 5,000 shares of common stock at $94.10 per share and 1,000 shares at $90.62 per share.
- Additionally, 4,492 shares were disposed of to cover exercise price and tax obligations, with a value of $197.96 per share.
- Flatt also acquired stock options: 5,000 options at an exercise price of $94.10 and 1,000 options at $90.62.
- These option grants are part of the 2020 Omnibus Equity Incentive Plan and are exempt from Section 16(b) under Rule 16b-3(d).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing. While there are acquisitions and option grants, which can be positive, the disposal of shares to cover taxes and exercise prices indicates some level of selling pressure.
Positives
- Acquisition of 5,000 common shares at $94.10 and 1,000 common shares at $90.62 indicates continued investment by the CEO.
- Grant of new stock options (5,000 at $94.10 and 1,000 at $90.62) suggests management's alignment with future company performance.
- The transactions are structured to be exempt from short-swing profit rules (Section 16(b)), indicating careful planning.
Negatives
- Disposal of 4,492 shares to cover exercise price and tax obligations at $197.96 per share could indicate a need for liquidity or a decision to realize gains.
Future Outlook
The filing does not contain explicit forward-looking statements or guidance. However, the grant of new stock options suggests management's confidence in the company's future performance.
Industry Context
StockSavvy.ai notes that insider transactions, particularly stock option grants and acquisitions by senior management like CEOs, are common in the healthcare sector as a means to incentivize performance and align executive interests with shareholders. The specific details of these transactions, including exercise prices and grant dates, are crucial for understanding executive compensation structures and potential future share liquidity.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Incentive Plan | Stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan. | 03/05/2024, 02/24/2025 | Standard practice for executive compensation and retention, aligning management with long-term shareholder value. |
| Rule 16b-3(d) Exemption | Grant and exercise of stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). | N/A | Ensures that these routine option grants and exercises by insiders do not trigger short-swing profit liability. |
Stakeholder Impact
- Shareholders: The acquisition of shares and grant of options by the CEO may be viewed positively, indicating confidence. However, the disposal of shares to cover taxes and exercise prices could be seen as a minor selling pressure.
Key Dates
| Date | Description |
|---|---|
| 05/14/2026 | Date of earliest transaction reported |
| 03/08/2024 | Exercisable date for an option to purchase common stock |
| 03/05/2025 | Grant date for stock options under the 2020 Omnibus Equity Incentive Plan |
| 02/28/2026 | Exercisable date for stock options |
| 02/23/2027 | Expiration date for stock options |
| 03/05/2028 | Expiration date for stock options |
| 03/05/2029 | Expiration date for stock options |
| 02/23/2031 | Expiration date for stock options |
| 05/18/2026 | Date of signature on the filing |
Keywords
Form 4, SEC Filing, Stock Transaction, Stock Options, Beneficial Ownership, National Healthcare Corp, NHC, Stephen Flatt, Insider Trading, Equity Incentive Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.